Smoking Cessation for Patients with Cardiovascular Disease: What is the Best Approach?

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.5, 2003-01, pp. : 339-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Smoking Cessation: COPD Patients' Perspective

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 36, Iss. 2, 2006-06 ,pp. : 107-110

John Wiley & Sons Inc

Access to resources Recommend Favorite

A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease

By Lock Kevin Wilson Koo Murphy Daniel Riesco Juan Antonio

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2613-2626

Informa Healthcare

Access to resources Recommend Favorite

Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease

By Wagena E.J.

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 381-403

Adis International

Access to resources Recommend Favorite

Pharmacological Treatment of the Psychosis of Alzheimer's Disease: What Is the Best Approach?

By Madhusoodanan Subramoniam Shah Payal Brenner Ronald Gupta Sanjay

CNS Drugs, Vol. 21, Iss. 2, 2007-01 ,pp. : 101-115

Adis International

Access to resources Recommend Favorite

Anxiety Symptoms in Elderly Patients with Depression: What is the Best Approach to Treatment?

By Lenze E.J.

Drugs & Aging, Vol. 19, Iss. 10, 2002-01 ,pp. : 753-760

Adis International

Access to resources Recommend Favorite